Monoclonal antibodies against growth hormone amplify and prolong its effects by sustaining GH binding to liver receptors, leading to increased IGF-I and IGFBP-3 synthesis.
No takes yet. Share an insight, caveat, or question.
MAb-GH complexes prolong IGF-I elevation in animals; hypothesis-generating for GH potentiation strategies pending human trials.
Beauloye et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: